At 29 days, the estimated cumulative rate of clinical resolution was 83% in tecovirimat recipients and 84% in those given placebo.
The test the US Centers for Disease Control and Prevention uses to identify clade I mpox cases is 'most likely not reliable' for detection of the substrain identified in the study, the authors say.
Another mpox study today showed that dose-sparing vaccine administration of the Jynneos vaccine appeared to have worked.
Receive the latest infectious disease information.
Rather than relying on reported cases, monitoring populations through blood testing is important for understanding how it spreads and for guiding targeted vaccination.
Adverse outcomes occurred in 94% of pregnancies during the first trimester.
Large family sizes and crowded living conditions may play a role in transmission.
The new Public Health Alerts initiative is designed to deliver information and early warnings about emerging health threats, enabling swift, informed responses across the US and globally.
Also, the WHO highlights more local transmission of clade 1b in multiple countries.
At eight months of follow-up, Jynneos recipients not vaccinated against smallpox had lower binding antibody concentrations than those with infection.
The county announced the detection yesterday, and it involves an adult with no recent travel to mpox-endemic areas.
The clade 1 case is the nation's first in a person with no recent travel history and the seventh clade 1 case in the country.
Rift Valley fever cases are rising in both people and animals in Senegal and Mauritania.
Whooping cough cases in Florida have risen by 81% this year compared with 2024.
